Title : Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer.

Pub. Date : 2003 Apr

PMID : 12684392






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. Tamoxifen tumor protein p53 Homo sapiens
2 RESULTS: In univariate analysis, both TP53 gene mutation (28% of the tumors) and a VEGF level above the median value were significantly associated with a short progression-free survival, post-relapse overall survival, and a poor rate of response to tamoxifen. Tamoxifen tumor protein p53 Homo sapiens
3 In Cox multivariate regression analysis including the traditional predictive factors, the addition of TP53 gene mutation and VEGF status, alone or in combination, significantly predicted a poor efficacy of tamoxifen treatment. Tamoxifen tumor protein p53 Homo sapiens
4 CONCLUSIONS: Combined TP53 gene mutation status and high VEGF levels of ER-positive primary breast tumors independently predict a poor course of the disease of patients with advanced breast cancer treated with tamoxifen. Tamoxifen tumor protein p53 Homo sapiens